ArticleCancers2024

Impact of Targeted Agents on Survival of Chronic Lymphocytic Leukemia Patients Fit for Fludarabine, Cyclophosphamide, and Rituximab (FCR) Relative to Age- and Sex-Matched Population.

Stefano Molica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.